These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 29328656)

  • 1. Design and Synthesis of Novel Reactive Oxygen Species Inducers for the Treatment of Pancreatic Ductal Adenocarcinoma.
    Kuang Y; Sechi M; Nurra S; Ljungman M; Neamati N
    J Med Chem; 2018 Feb; 61(4):1576-1594. PubMed ID: 29328656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design and discovery of novel quinazolinedione-based redox modulators as therapies for pancreatic cancer.
    Pathania D; Sechi M; Palomba M; Sanna V; Berrettini F; Sias A; Taheri L; Neamati N
    Biochim Biophys Acta; 2014 Jan; 1840(1):332-43. PubMed ID: 23954204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted Nanoparticles for the Delivery of Novel Bioactive Molecules to Pancreatic Cancer Cells.
    Sanna V; Nurra S; Pala N; Marceddu S; Pathania D; Neamati N; Sechi M
    J Med Chem; 2016 Jun; 59(11):5209-20. PubMed ID: 27139920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arsenic trioxide plus PX-478 achieves effective treatment in pancreatic ductal adenocarcinoma.
    Lang M; Wang X; Wang H; Dong J; Lan C; Hao J; Huang C; Li X; Yu M; Yang Y; Yang S; Ren H
    Cancer Lett; 2016 Aug; 378(2):87-96. PubMed ID: 27212442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of Aurora Kinase A Induces Necroptosis in Pancreatic Carcinoma.
    Xie Y; Zhu S; Zhong M; Yang M; Sun X; Liu J; Kroemer G; Lotze M; Zeh HJ; Kang R; Tang D
    Gastroenterology; 2017 Nov; 153(5):1429-1443.e5. PubMed ID: 28764929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of cell death in pancreatic ductal adenocarcinoma by indirubin 3'-oxime and 5-methoxyindirubin 3'-oxime in vitro and in vivo.
    Sano M; Ichimaru Y; Kurita M; Hayashi E; Homma T; Saito H; Masuda S; Nemoto N; Hemmi A; Suzuki T; Miyairi S; Hao H
    Cancer Lett; 2017 Jul; 397():72-82. PubMed ID: 28347789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. UCP2 inhibition induces ROS/Akt/mTOR axis: Role of GAPDH nuclear translocation in genipin/everolimus anticancer synergism.
    Dando I; Pacchiana R; Pozza ED; Cataldo I; Bruno S; Conti P; Cordani M; Grimaldi A; Butera G; Caraglia M; Scarpa A; Palmieri M; Donadelli M
    Free Radic Biol Med; 2017 Dec; 113():176-189. PubMed ID: 28962872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A tunable delivery platform to provide local chemotherapy for pancreatic ductal adenocarcinoma.
    Indolfi L; Ligorio M; Ting DT; Xega K; Tzafriri AR; Bersani F; Aceto N; Thapar V; Fuchs BC; Deshpande V; Baker AB; Ferrone CR; Haber DA; Langer R; Clark JW; Edelman ER
    Biomaterials; 2016 Jul; 93():71-82. PubMed ID: 27082874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting Redox Metabolism in Pancreatic Cancer.
    Abdel Hadi N; Reyes-Castellanos G; Carrier A
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33546421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A selective mitochondrial-targeted chlorambucil with remarkable cytotoxicity in breast and pancreatic cancers.
    Millard M; Gallagher JD; Olenyuk BZ; Neamati N
    J Med Chem; 2013 Nov; 56(22):9170-9. PubMed ID: 24147900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. JTC801 Induces pH-dependent Death Specifically in Cancer Cells and Slows Growth of Tumors in Mice.
    Song X; Zhu S; Xie Y; Liu J; Sun L; Zeng D; Wang P; Ma X; Kroemer G; Bartlett DL; Billiar TR; Lotze MT; Zeh HJ; Kang R; Tang D
    Gastroenterology; 2018 Apr; 154(5):1480-1493. PubMed ID: 29248440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Novel Redox Modulator Induces a GPX4-Mediated Cell Death That Is Dependent on Iron and Reactive Oxygen Species.
    Hu S; Sechi M; Singh PK; Dai L; McCann S; Sun D; Ljungman M; Neamati N
    J Med Chem; 2020 Sep; 63(17):9838-9855. PubMed ID: 32809827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SOX2 functions as a molecular rheostat to control the growth, tumorigenicity and drug responses of pancreatic ductal adenocarcinoma cells.
    Wuebben EL; Wilder PJ; Cox JL; Grunkemeyer JA; Caffrey T; Hollingsworth MA; Rizzino A
    Oncotarget; 2016 Jun; 7(23):34890-906. PubMed ID: 27145457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct Pharmacological Targeting of a Mitochondrial Ion Channel Selectively Kills Tumor Cells In Vivo.
    Leanza L; Romio M; Becker KA; Azzolini M; Trentin L; Managò A; Venturini E; Zaccagnino A; Mattarei A; Carraretto L; Urbani A; Kadow S; Biasutto L; Martini V; Severin F; Peruzzo R; Trimarco V; Egberts JH; Hauser C; Visentin A; Semenzato G; Kalthoff H; Zoratti M; Gulbins E; Paradisi C; Szabo I
    Cancer Cell; 2017 Apr; 31(4):516-531.e10. PubMed ID: 28399409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aqueous extracts of Paeonia suffruticosa modulates mitochondrial proteostasis by reactive oxygen species-induced endoplasmic reticulum stress in pancreatic cancer cells.
    Liu YH; Weng YP; Tsai HY; Chen CJ; Lee DY; Hsieh CL; Wu YC; Lin JY
    Phytomedicine; 2018 Jul; 46():184-192. PubMed ID: 30097117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of GOT1 Inhibitors from a Marine-Derived
    Yan S; Qi C; Song W; Xu Q; Gu L; Sun W; Zhang Y
    Mar Drugs; 2021 Oct; 19(11):. PubMed ID: 34822459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitochondria-Targeted Analogues of Metformin Exhibit Enhanced Antiproliferative and Radiosensitizing Effects in Pancreatic Cancer Cells.
    Cheng G; Zielonka J; Ouari O; Lopez M; McAllister D; Boyle K; Barrios CS; Weber JJ; Johnson BD; Hardy M; Dwinell MB; Kalyanaraman B
    Cancer Res; 2016 Jul; 76(13):3904-15. PubMed ID: 27216187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measurement of Reactive Oxygen Species by Fluorescent Probes in Pancreatic Cancer Cells.
    Luo Y; Wang D; Abbruzzese JL; Lu W
    Methods Mol Biol; 2019; 1882():207-219. PubMed ID: 30378057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. KRas4B-PDE6δ complex stabilization by small molecules obtained by virtual screening affects Ras signaling in pancreatic cancer.
    Casique-Aguirre D; Briseño-Díaz P; García-Gutiérrez P; la Rosa CHG; Quintero-Barceinas RS; Rojo-Domínguez A; Vergara I; Medina LA; Correa-Basurto J; Bello M; Hernández-Rivas R; Del RocioThompson-Bonilla M; Vargas M
    BMC Cancer; 2018 Dec; 18(1):1299. PubMed ID: 30594165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stromal remodeling by the BET bromodomain inhibitor JQ1 suppresses the progression of human pancreatic cancer.
    Yamamoto K; Tateishi K; Kudo Y; Hoshikawa M; Tanaka M; Nakatsuka T; Fujiwara H; Miyabayashi K; Takahashi R; Tanaka Y; Ijichi H; Nakai Y; Isayama H; Morishita Y; Aoki T; Sakamoto Y; Hasegawa K; Kokudo N; Fukayama M; Koike K
    Oncotarget; 2016 Sep; 7(38):61469-61484. PubMed ID: 27528027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.